The computationally predicted drug-likeness, pharmacokinetics properties, medicinal chemistry parameters, and toxicity properties of Cucurbita maxima compounds
- PMID: 38690404
- PMCID: PMC11058453
- DOI: 10.12688/f1000research.127126.1
The computationally predicted drug-likeness, pharmacokinetics properties, medicinal chemistry parameters, and toxicity properties of Cucurbita maxima compounds
Abstract
Natural compounds are increasingly becoming an important source of drug leads for computer-aided drug design approaches. Cucurbita maxima has been observed to have medicinal properties and can, therefore, be a potential source of novel drug leads. However, before compounds can be synthesized in the lab for tests, modern approaches require that the candidate compounds be screened for drug-likeness characteristics and toxicity, among others. In this work, the computational tools, SwissADME and DataWarrior were used to screen C. maxima compounds for their potential consideration as drug leads. A total of 130 compounds, downloaded from the LOTUS natural products database, were computationally analysed. The data set presented in this work will be useful to researchers searching for novel drug leads based on natural compounds.
Keywords: Cucurbita maxima; druglikeness; medicinal plants; natural products; pharmacoinformatics.
Copyright: © 2022 Shoko R.
Conflict of interest statement
No competing interests were disclosed.
Similar articles
-
Synthesis, in-vitro inhibition of cyclooxygenases and in silico studies of new isoxazole derivatives.Front Chem. 2023 Sep 6;11:1222047. doi: 10.3389/fchem.2023.1222047. eCollection 2023. Front Chem. 2023. PMID: 37744065 Free PMC article.
-
Characterization of partially purified alkaloids from Cucurbita maxima seed and evaluation of their antioxidant activity in human erythrocytes and leukocytes.J Food Biochem. 2020 Jul;44(7):e13225. doi: 10.1111/jfbc.13225. Epub 2020 Apr 17. J Food Biochem. 2020. Retraction in: J Food Biochem. 2021 Jul 1:e13839. doi: 10.1111/jfbc.13839. PMID: 32301513 Retracted.
-
Advances in In-Silico based Predictive In-Vivo Profiling of Novel Potent β-Glucuronidase Inhibitors.Curr Cancer Drug Targets. 2019;19(11):906-918. doi: 10.2174/1568009619666190320102238. Curr Cancer Drug Targets. 2019. PMID: 30894110
-
Computational Methodologies in the Exploration of Marine Natural Product Leads.Mar Drugs. 2018 Jul 13;16(7):236. doi: 10.3390/md16070236. Mar Drugs. 2018. PMID: 30011882 Free PMC article. Review.
-
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.Int J Mol Sci. 2018 May 25;19(6):1578. doi: 10.3390/ijms19061578. Int J Mol Sci. 2018. PMID: 29799486 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Miscellaneous